Dersleri yüzünden oldukça stresli bir ruh haline sikiş hikayeleri bürünüp özel matematik dersinden önce rahatlayabilmek için amatör pornolar kendisini yatak odasına kapatan genç adam telefonundan porno resimleri açtığı porno filmini keyifle seyir ederek yatağını mobil porno okşar ruh dinlendirici olduğunu iddia ettikleri özel sex resim bir masaj salonunda çalışan genç masör hem sağlık hem de huzur sikiş için gelip masaj yaptıracak olan kadını gördüğünde porn nutku tutulur tüm gün boyu seksi lezbiyenleri sikiş dikizleyerek onları en savunmasız anlarında fotoğraflayan azılı erkek lavaboya geçerek fotoğraflara bakıp koca yarağını keyifle okşamaya başlar

GET THE APP

Risks and Future of Cancer Treatment | OMICS International| Abstract
ISSN 2472-0429

Advances in Cancer Prevention
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • Adv Cancer Prev,

Risks and Future of Cancer Treatment

Sakhri Selma*
Department of Medical Oncology, Centre hospitalier universitaire de Tizi Ouzou, Algeria, Africa
*Corresponding Author : Sakhri Selma, Department of Medical Oncology, Centre hospitalier universitaire de Tizi Ouzou, Algeria, Africa, Email: sakhri_selma@yahoo.fr

Received Date: Feb 28, 2023 / Published Date: Mar 28, 2023

Abstract

Predictive factor is a measurement that predicts response or lack of response to a specific treatment. Some common examples include epidermal growth factor receptor (EGFR) mutation in lung cancer that determines response to EGFR inhibitor like gefitinib, Her2/neu amplification in breast cancer that determines response to anti-Her2 therapy like trastuzumab or lapatinib, and K-RAS/N-RAS mutations in colorectal cancer which are a negative predictive factorfor response to EGFR monoclonal antibody such as cetuximab.

Citation: Selma S (2023) Risks and Future of Cancer Treatment. Adv Cancer Prev7: 156.

Copyright: © 2023 Selma S. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top